RecruitingACTRN12623000711617

Utility of Non-invasive Cardiac Output Estimation in Patients Undergoing Continuous Renal Replacement Therapy and Haemodialysis

Sponsor

Austin Health

Enrollment

30 participants

Start Date

Aug 26, 2022

Study Type

Observational

Conditions

renal replacement therapy

Summary

To assess the clinical utility of using a non-invasive haemodynamic monitoring device (the Clearsight TM system) in the cardiac assessment of patients undergoing CRRT and IHD To evaluate the feasibility of using the Clearsight TM system on patients that are currently on CRRT To evaluate the feasibility of using the Clearsight TM system on patients that are currently on IHD To evaluate the haemodynamic changes that occur during a CRRT session and how are these changes correlated to the clinical status of the patient To evaluate the haemodynamic changes that occur during an IHD session and how are these changes correlated to the clinical status of the patient Patients rercruited would have already been receiving IHD or CRRT and were then approached to enter this study. Patients would not have their IHD or CRRT intervention altered in anyway. The ClearSight cardiac output monitoring device is a small pressure cuff that is applied the the middle phalanx of either the 2nd, 3rd or 4th finger. This allows for continuous monitoring of cardiac output

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

When patients with kidney failure undergo dialysis — either continuous (CRRT) or intermittent haemodialysis (IHD) — monitoring the health of the heart and circulation is important, especially since dialysis itself can affect blood pressure and cardiac function. Traditionally, measuring cardiac output (how much blood the heart pumps) requires invasive procedures. This study is evaluating a simple, non-invasive device called the ClearSight system, which measures cardiac output using a small finger cuff. The study aims to find out whether the ClearSight system works reliably in patients on dialysis, and what cardiovascular changes occur during a dialysis session. Participants will simply wear the finger cuff while they undergo their usual dialysis treatment — no changes are made to their dialysis. Results could help clinicians better monitor and manage the cardiovascular health of dialysis patients. You may be eligible if you are aged 18 or older, are currently undergoing CRRT or intermittent haemodialysis at Austin Health, have at least one arm without an arteriovenous fistula or graft, and can provide consent. People with severe peripheral vascular disease, Raynaud's disease, or who are intubated are not eligible.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Participants: participants will undergo intermittent haemodialysis (IHD) or continuous renal replacement therapy (CRRT) as per usual prescribed by nephrologist or intensivist. The additional requirement that participants undergo as part of the study is to allow for an inflatable cuff to be placed over the middle phalanx of either hand of the 2nd, 3rd or 4th finger. They will be also asked of their experiences with the device being applied during time on haemodialysis. The on patient will only undergo monitoring during a single dialysis session. Monitoring: use of the device and monitoring is continuous. Patients will be monitored with device on up to 30 minutes before and after their IHD or CRRT